DUBLIN--(BUSINESS WIRE)--The "In-vitro Diagnostics Market Analysis by Product & Service, by Technology, by Application, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The in-vitro diagnostics market size is estimated to be USD 109.5 billion in 2021 and is expected to witness a CAGR of 5.73% during the forecast period 2022-2029.
Companies Mentioned
- Roche Diagnostics (Switzerland)
- Siemens Healthineers (Germany)
- Danaher Corporation (US)
- Abbott (US)
- Thermo Fisher Scientific (US). Other players in this market are Johnson & Johnson (US)
- Becton
- Dickinson and Company (US)
- Bio-Rad Laboratories (US)
- Sysmex Corporation (Japan)
- bioMerieux (France)
- DiaSorin (Italy)
- Ortho Clinical Diagnostics (US)
- QIAGEN N.V. (Netherlands)
The increasing geriatric population and the higher margins in the incidence of chronic and infectious diseases, rising acceptance of fully automated and point-of-care instruments in developed regions, growing awareness of disease diagnosis in developing regions, and escalating R&D investments by market players to launch the new IVD products expected to contribute the market growth.
However, unfavourable reimbursement scenario is expected to restrain the market growth.
Market Segmentation:
Product & Service (Revenue, USD Billion)
- Data Management Software
- Reagents & Kits
- Instruments
- Services
By Technology (Revenue, USD Billion)
- Coagulation & Haemostasis
- Molecular Diagnostics
- Clinical Chemistry
- Urinalysis
- Microbiology
- Immunoassay
- Haematology
- Others
By Application (Revenue, USD Billion)
- Autoimmune Diseases
- Infectious Diseases
- Cardiology
- Oncology
- Nephrology
- Autoimmune Diseases
- Drug Testing
By End user (Revenue, USD Billion)
- Clinical Laboratories
- Point-of-care Testing Centres
- Academic Institutes
- Hospital Laboratories
- Patients
- Others
By Region (Revenue, USD Billion)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/v89lxx
